The pharma group lifted its guidance citing strong results to date, and reported a rise in sales excluding currency movements ...

Investing.com -- Swiss drugmaker Roche Holding AG (SIX: ROG) on Thursday raised its full-year profit outlook after reporting ...

Roche (OTCQX:RHHBY) has signed an agreement with China's Hansoh Pharma to obtain exclusive licensing rights for a cancer ...

Swiss drugmaker Roche on Thursday lifted its full-year guidance even after reporting nine-month sales that were below ...

Shares in Roche fell 1% during the third quarter, but rose 8.4% since the beginning of the year through Tuesday's close. WHAT TO WATCH:--DRUG PRICING: The impact of President Trum ...

The drug is the only medicine of its kind proven to help patients with lupus nephritis regain full kidney response, the ...

With the lupus treatment landscape poised for a shake-up, Roche is hitting t | Early Monday, Roche announced that the FDA ...

The Supreme Court upheld Delhi HC's interim order allowing Natco Pharma to manufacture and sell a generic version of Roche's ...

The US Food and Drug Administration’s (FDA) recent clearance of Roche’s blood-based Alzheimer’s disease test will boost ...

The top court said the orders impugned by Roche were interim orders and Roche was free to argue its case further before the ...

For years, MASH was where drug development dreams went to die.  | After Rezdiffra’s approval and Wegovy’s label expansion, ...

Swiss exports to the United States rebounded sharply in September, with pharmaceutical companies ramping up their shipments ...